"Nonprescription Drugs" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Medicines that can be sold legally without a DRUG PRESCRIPTION.
| Descriptor ID |
D004366
|
| MeSH Number(s) |
D26.530
|
| Concept/Terms |
Nonprescription Drugs- Nonprescription Drugs
- Drugs, Nonprescription
- Medicines, Patent
- OTC Drugs
- Drugs, OTC
- Over-the-Counter Drugs
- Drugs, Over-the-Counter
- Over the Counter Drugs
- Patent Medicines
- Drugs, Non-Prescription
- Drugs, Non Prescription
- Non-Prescription Drugs
- Non Prescription Drugs
|
Below are MeSH descriptors whose meaning is more general than "Nonprescription Drugs".
Below are MeSH descriptors whose meaning is more specific than "Nonprescription Drugs".
This graph shows the total number of publications written about "Nonprescription Drugs" by people in this website by year, and whether "Nonprescription Drugs" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 1994 | 2 | 0 | 2 |
| 1997 | 1 | 2 | 3 |
| 1999 | 1 | 0 | 1 |
| 2000 | 2 | 0 | 2 |
| 2001 | 2 | 0 | 2 |
| 2002 | 14 | 7 | 21 |
| 2003 | 11 | 9 | 20 |
| 2004 | 20 | 4 | 24 |
| 2005 | 24 | 6 | 30 |
| 2006 | 7 | 12 | 19 |
| 2007 | 18 | 6 | 24 |
| 2008 | 19 | 19 | 38 |
| 2009 | 30 | 18 | 48 |
| 2010 | 18 | 18 | 36 |
| 2011 | 28 | 14 | 42 |
| 2012 | 25 | 8 | 33 |
| 2013 | 36 | 16 | 52 |
| 2014 | 44 | 15 | 59 |
| 2015 | 26 | 16 | 42 |
| 2016 | 31 | 15 | 46 |
| 2017 | 20 | 6 | 26 |
| 2018 | 21 | 18 | 39 |
| 2019 | 7 | 7 | 14 |
| 2020 | 2 | 2 | 4 |
| 2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Nonprescription Drugs" by people in Profiles.
-
Patterns of prescription dispensation and over-the-counter medication sales in Sweden during the COVID-19 pandemic. PLoS One. 2021; 16(8):e0253944.
-
Care of Parkinson's disease (PD) patients in times of covid-19 pandemic. Diabetes Metab Syndr. 2021 Jul-Aug; 15(4):102168.
-
Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2021 Aug; 60:102744.
-
Shifts in allergy practice in a COVID-19 world: Implications of pre-COVID-19 national health care provider and patient surveys of treatments for nasal allergies. Allergy Asthma Proc. 2021 07 24; 42(4):301-309.
-
Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19. Endocr Relat Cancer. 2021 02; 28(2):R47-R53.
-
20-Week Study of Clinical Outcomes of Over-the-Counter COVID-19 Prophylaxis and Treatment. J Evid Based Integr Med. 2021 Jan-Dec; 26:2515690X211026193.
-
Melatonin Use in Psychiatry-Quo Vadis? Am J Ther. 2020 Sep/Oct; 27(5):e495-e499.
-
The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence. Pharmacol Res. 2020 07; 157:104882.
-
Can melatonin reduce the severity of COVID-19 pandemic? Int Rev Immunol. 2020; 39(4):153-162.
-
[Recent advances in treatment of viral pneumonia using Chinese patent medicine]. Zhongguo Zhong Yao Za Zhi. 2020 Apr; 45(7):1509-1514.